Calcium regulates the expression of insulin-like growth factor binding protein-3 by the human keratinocyte cell line HaCaT

Journal of Investigative Dermatology

Volumn 116, Issue 4, 2001, Pages 491-497

  Edmondson, S R ^a   Werther, G A ^a   Wraight, C J ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Calcium; Epidermis; IGF IR; IGFBP 3; Keratinocyte

Indexed keywords

CALCIUM; MESSENGER RNA; PROFILAGGRIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 0035052967     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202X.2001.TEMP.doc.x     Document Type: Article

References (50)

1. In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors
2. Localization of messenger ribonucleic acid for insulin-like growth factor-binding proteins in human skin by in situ hybridization
3. Vitamin D, calcium and epidermal differentiation
4. 2+
5. N-myc regulation of type 1 insulin-like growth factor receptor in a human neuroblastoma cell line
6. Factors regulating insulin-like growth factor-binding protein-3 binding, processing, and potentiation of insulin-like growth factor action
7. Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in human keratinocytes is regulated by EGF and TGFbeta 1
8. Biphasic concentration dependency of stimulation of myoblast differentiation by somatomedins
9. The epidermis: Rising to the surface
10. Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma
11. Stimulation versus inhibition of keratinocyte growth by 1,25-dihydroxyvitamin D3: Dependence on cell culture conditions
12. Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus
13. Calcium regulation of cell-cell contact and differentiation of epidermal cells in culture. An ultrastructural study
14. The insulin-like growth factor 1 receptor is expressed by epithelial cells with proliferative potential in human epidermis and skin appendages: Correlation of increased expression with epidermal hyperplasia
15. Expression of IGFBP-2, -3, and -4 mRNA during differentiation of Caco-2 colon epithelial cells
16. Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy
17. Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism
18. Differential autocrine regulation of intestine epithelial cell proliferation and differentiation by insulin-like growth factor (IGF) system components
19. Decreased steady-state insulin-like growth factor binding protein-3 (IGFBP-3) mRNA level is associated with differentiation of cultured porcine myogenic cells
20. Insulin-like growth factors and their binding proteins: Biological actions
21. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression
22. A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-β and insulin-like growth factor binding protein-6 in a calcium and cell density-dependent manner
23. Insulin-like growth factor-I-mediated neurite outgrowth in vitro requires mitogen-activated protein kinase activation
24. The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor
25. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
26. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-I) and type 1 IGF receptor (Igf1r)
27. Growth inhibition and differentiation of the human colon carcinoma cell line, Caco-2, by constitutive expression of insulin-like growth factor binding protein-3
28. HaCaT human keratinocytes express IGF-II, IGFBP-6, and an acid-activated protease with activity against IGFBP-6
29. Identification of insulin-like growth factor binding proteins from cultured human epidermal keratinocytes
30. Calcium regulation of growth and differentiation of normal human keratinocytes: Modulation of differentiation competence by stages of growth and extracellular calcium
31. Characterization of the human epidermal profilaggrin gene. Genomic organization and identification of an S-100-like calcium binding domain at the amino terminus
32. Insulin-like growth factor (IGF) -binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism
33. The role of IGF-I in human skin and its appendages: Morphogen as well as mitogen?
34. The amido black assay: A simple and quantitative multipurpose test of adhesion, proliferation and cytotoxicity in microplate cultures of keratinocytes (HaCaT) and other cell types growing adherently or in suspension
35. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1-2-3-4-5 and -6)
36. Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium
37. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes
38. Cloning and expression of human insulin-like growth factor binding protein 3
39. Insulin-like growth factors I and II are autocrine factors in stimulating proteoglycan synthesis, a marker of differentiated chondrocytes, acting through their respective receptors on a clonal human chondrosarcoma-derived chondrocyte cell line, HCS-2/8
40. Expression of growth hormone receptor, insulin-like growth factor I (IGF-I) and IGF-I receptor mRNA and proteins in human skin
41. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene
42. Growth and differentiation signals by the insulin-like growth factor 1 receptor in hemopoietic cells are mediated through different pathways
43. 1 Alpha, 25-dihydroxy-16-ene-23-yne-26,27-hexafluoro-cholecalciferol (Ro24-5531) modulation of insulin-like growth factor-binding protein-3 and induction of differentiation and growth arrest in a human osteosarcoma cell line
44. Insulin-like growth factor-I and epidermal growth factor regulate insulin-like growth factor binding protein-3 (IGFBP-3) in the human keratinocyte cell line HaCaT
45. Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in the psoriatic lesion
46. Insulin-like growth factors (IGFs) and IGF-binding proteins in human skin interstitial fluid
47. Proteolysis of insulin-like growth factor-binding protein-3 by human skin keratinocytes in culture in comparison to that in skin interstitial fluid: The role and regulation of components of the plasmin system
48. Effect of insulin-like growth factor (IGF) -I and Des (1-3) IGF-1 on the level of IGF binding protein-3 and IGF binding protein-3 mRNA in cultured porcine embryonic muscle cells
49. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation
50. Signal transduction for proliferation and differentiation in keratinocytes